2 unknown. 2 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Unknown 2 |
| Phase 2 | 1 | Unknown 1 |
Follow Uterine Fibroids: new trials by email Literature Review of Uterine Fibroids trials Research Report on Uterine Fibroids
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy and Safety of BG2109 in Subjects With Heavy Menstrual Bleeding Associated With Uterine Fibroids. BG2109, Placebo for BG2109, Placebo for add-back therapy - Uterine Fibroids, Heavy Menstrual Bleeding | Phase 3 | Unknown | Bio Genuine (Shanghai) Biotech Co., Ltd. | 312 | 2022-12-16 | 2023-03-21 |
| Study of Volume Reduction of Uterine Fibroids After Embolization or Microwave Treatment Microwave treatment, uterine artery embolization - Uterine Fibroids | Phase 2 / Phase 3 | Unknown | Karolinska Institutet | 36 | 2017-01-23 | 2018-10-02 |
Leiomyoma (2) · Menorrhagia (1)
Neoplasms (2) · Neoplasms by Histologic Type (2) · Neoplasms, Connective and Soft Tissue (2) · Neoplasms, Muscle Tissue (2) · Female Urogenital Diseases (1) · Female Urogenital Diseases and Pregnancy Complications (1) · Genital Diseases (1) · Genital Diseases, Female (1) · Hemorrhage (1) · Menstruation Disturbances (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1) · Urogenital Diseases (1) · Uterine Diseases (1) · Uterine Hemorrhage (1)
Uterine Artery Embolization (1)
Bio Genuine (Shanghai) Biotech Co., Ltd. (1) · Karolinska Institutet (1)
China (1) · Sweden (1)
Congjian Xu (1) · Helena Kopp Kallner, MD, PhD (1)